Spectrofluorimetric and spectrophotometric determination of oxamniquine in pharmaceuticals and biological fluids via derivatization with 4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl)

Journal of the Chinese Chemical Society

Volumn 56, Issue 3, 2009, Pages 485-492

  El Enany, N ^a   Ahmida, N ^b   Bela, F ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b Pharmaceutical Chemistry Department   (Libyan Arab Jamahiriya)

Author keywords

4 Chloro 7 nitrobenzo 2 oxa 1,3 diazole (NBD Cl); Dosage forms; Oxamniquine; Spectrofluorimetry; Spectrophotometry; Spiked human plasma

Indexed keywords

EID: 69549128052     PISSN: 00094536     EISSN: None     Source Type: Journal    
DOI: 10.1002/jccs.200900073     Document Type: Article

References (30)

1. Delgado, J. N.; Gisvold, O.; Remers, W. A. Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry, 9th ed.; Lippincott Williams & Wilkins: Philadelphia, 1991; p 184.
2. The USP Pharmacopoeia XXIII, NF 18, The US Pharmaceutical Convention, Rockville, 1995; p 1120.
3. Hassan, S.-M.; Belal, F.; Sharf-El-Din, M.; Sultan, M. Analyst (Cambridge, U. K.) 1988, 113, 1807.
4. Bebawy, L.-I.; El-Kelani, K.; Abdel Fattah, L.; Ahmad, A.-K. J. Pharm. Sci. 1997, 86, 1030.
5. Rizk, M.; Belal, F.; Ibrahim, F.; Ahmed, S.-M.; El-Enany, N.-M. J. Pharm. Biomed. Anal. 2000, 23, 503.
6. Korolkovas, A.; Haraguchi, T. Rev. Farm. Bioquim Univ. Sao Paulo. 1980, 16, 12;
7. thro. Chem. Abstr. 1981, Vol. 94, pp 7846e.
8. thro. Chem. Abstr. 1981, Vol.94, pp 7846e.
9. Woolhouse, N.-M.; Wood, P.-R. J. Pharm. Sci. 1977, 66, 429.
10. Jun, H.-W.; Radwan, M.-A. Anal. Lett. 1985, 18, 1345.
11. Pierri, E.-G.; Almeida, A.-E.; Gremiao, M.-P. J. Pharm. Biomed. Anal. 2001, 26, 675.
12. Masimirembwa, C.-M.; Hasler, J.-A.; Johansson, I. Eur. J. Clin. Pharmacol. 1995, 48, 35.
13. Abushoffa, M.-A.; Clark, B.-J. J. Chromatogr. 1995, 700, 51.
14. Noctor, T.-A.; Fell, A.-F.; Kaye, B. Chirality 1990, 2, 269.
15. Fell, A.-F.; Noctor, T.-A.; Mama, J.-E.; Clark, B. J. J. Chromatogr. 1988, 434, 377.
16. Belal, F.; Aly, F.-A. Electroanalysis 1995, 7, 483.
17. Mohamed, M.-Y.; El-Gendy, A.-E.; El-Bardicy, M. G.; Tawakol, M. S.; Ahmed, A. K. S. Spectrosc. Lett. 1996, 29, 299.
18. El-Enany, N.; Belal, F.; Rizk, M. J. Fluoresc. 2008, 18, 349.
19. Rizk, M.; Belal, F.; Ibrahim, F.; Ahmed, S. M.; El-Enany, N. M. IlFarmaco 1999, 54, 47.
20. El-Emam, A.-A.; Hansen, S. H.; Moustafa, M. A.; El-Ashry, S. M.; El-Sherbiny, D. T. J. Pharm. Biomed. Anal. 2004, 34, 35.
21. El-Enany, N. J. AOAC Int. 2003, 86, 209.
22. El-Enany, N.; Belal, F.; Rizk, M. Sci. Pharm. 2006, 74, 99.
23. El-Enany, N.; El-Sherbiny, D.; Belal, F. Chem. Pharm. Bull. 2007, 55, 1662.
24. TatarUlu, S. J. Chromatogr. B. 2006, 834, 62.
25. Erturk, S.; Cetin, S.-M.; Atmaca, S.; Ersoy, L.; Baktr, G. Ther. Drug Monit. 2005, 27, 38.
26. Miyano, H.; Toyo'oka, T.; Miyano, H. Anal. Chim. Acta. 1985, 170, 81.
27. Tran, C. D.; Van Fleet, T. A. Anal. Chem. 1988, 60, 2462.
28. Guidance for Industry; Q2B of Analytical Procedures:Methodology; International Conference on Hormonization (ICH), November 1996 http://www.fda.gov/eder/guidance/1320fnl. pdf (accessed September 1, 2004).
29. th ed.; Prentice Hall: England, 2005; p 256.
30. Rose, J. Advanced Physico-Chemical Experiments; Pitman: London, 1964.